09:51 AM EST - Sernova Corp. : Announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) for the company’s Hemophilia A program. Sernova Corp.
shares T.SVA are trading up $0.02 at $2.75.
